AnaptysBio
ANAB
ANAB
122 hedge funds and large institutions have $720M invested in AnaptysBio in 2021 Q2 according to their latest regulatory filings, with 16 funds opening new positions, 25 increasing their positions, 50 reducing their positions, and 16 closing their positions.
New
Increased
Maintained
Reduced
Closed
more capital invested
Capital invested by funds: $ → $
more funds holding
Funds holding: →
more funds holding in top 10
Funds holding in top 10: →
more first-time investments, than exits
New positions opened: | Existing positions closed:
5.08% less ownership
Funds ownership: 106.62% → 101.54% (-5.1%)
32% less call options, than puts
Call options by funds: $1.43M | Put options by funds: $2.11M
50% less repeat investments, than reductions
Existing positions increased: 25 | Existing positions reduced: 50
Holders
122
Holding in Top 10
2
Calls
$1.43M
Puts
$2.11M
Top Buyers
| 1 | +$10.4M | |
| 2 | +$9.58M | |
| 3 | +$3.02M | |
| 4 |
WP
Woodline Partners
San Francisco,
California
|
+$2.88M |
| 5 |
Millennium Management
New York
|
+$2.79M |
Top Sellers
| 1 | -$12.4M | |
| 2 | -$11.4M | |
| 3 | -$9.87M | |
| 4 |
CAM
Cormorant Asset Management
Boston,
Massachusetts
|
-$6.87M |
| 5 |
BlackRock
New York
|
-$6.33M |